BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23372725)

  • 1. Study of the integrated immune response induced by an inactivated EV71 vaccine.
    Liu L; Zhang Y; Wang J; Zhao H; Jiang L; Che Y; Shi H; Li R; Mo Z; Huang T; Liang Z; Mao Q; Wang L; Dong C; Liao Y; Guo L; Yang E; Pu J; Yue L; Zhou Z; Li Q
    PLoS One; 2013; 8(1):e54451. PubMed ID: 23372725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children.
    Zhang Y; Wang L; Liao Y; Liu L; Ma K; Yang E; Wang J; Che Y; Jiang L; Pu J; Guo L; Feng M; Liang Y; Cui W; Yang H; Li Q
    Vaccine; 2015 Nov; 33(46):6290-7. PubMed ID: 26419198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
    Zhu F; Xu W; Xia J; Liang Z; Liu Y; Zhang X; Tan X; Wang L; Mao Q; Wu J; Hu Y; Ji T; Song L; Liang Q; Zhang B; Gao Q; Li J; Wang S; Hu Y; Gu S; Zhang J; Yao G; Gu J; Wang X; Zhou Y; Chen C; Zhang M; Cao M; Wang J; Wang H; Wang N
    N Engl J Med; 2014 Feb; 370(9):818-28. PubMed ID: 24571754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
    In HJ; Lim H; Lee JA; Kim HJ; Kim JW; Hyeon JY; Yeo SG; Lee JW; Yoo JS; Choi YK; Lee SW
    PLoS One; 2017; 12(5):e0178259. PubMed ID: 28542556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inactivated enterovirus 71 vaccine in healthy children.
    Li R; Liu L; Mo Z; Wang X; Xia J; Liang Z; Zhang Y; Li Y; Mao Q; Wang J; Jiang L; Dong C; Che Y; Huang T; Jiang Z; Xie Z; Wang L; Liao Y; Liang Y; Nong Y; Liu J; Zhao H; Na R; Guo L; Pu J; Yang E; Sun L; Cui P; Shi H; Wang J; Li Q
    N Engl J Med; 2014 Feb; 370(9):829-37. PubMed ID: 24571755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
    PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A safety study of inactivated Enterovirus 71 vaccine.
    Zhou XB; Lu JJ; Jiang YS; Huo Y; Wang JF; Zhou KF; Li B
    Hum Vaccin Immunother; 2013 Jul; 9(7):1430-7. PubMed ID: 23571172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial.
    Zhang W; Kong Y; Jiang Z; Li C; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Apr; 12(4):922-30. PubMed ID: 26837471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of enterovirus 71 vaccines.
    Chong P; Liu CC; Chow YH; Chou AH; Klein M
    Clin Infect Dis; 2015 Mar; 60(5):797-803. PubMed ID: 25352588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate.
    Zhou SL; Ying XL; Han X; Sun XX; Jin Q; Yang F
    J Med Virol; 2015 Feb; 87(2):256-62. PubMed ID: 25043151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice.
    Pathinayake PS; Gayan Chathuranga WA; Lee HC; Chowdhury MYE; Sung MH; Lee JS; Kim CJ
    Arch Virol; 2018 Aug; 163(8):2073-2083. PubMed ID: 29619599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
    Fan S; Liao Y; Jiang G; Jiang L; Wang L; Xu X; Feng M; Yang E; Zhang Y; Cui W; Li Q
    Vaccine; 2020 Feb; 38(8):2034-2044. PubMed ID: 31982260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.
    Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX
    Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children.
    Li JX; Song YF; Wang L; Zhang XF; Hu YS; Hu YM; Xia JL; Li J; Zhu FC
    Expert Rev Vaccines; 2016; 15(1):129-37. PubMed ID: 26460695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.